Zimmer Biomet Holdings (ZBH) Operating Income Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Operating Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn | 74.18% |
| 10 | Zimmer Biomet Holdings | 18.10 Bn | 17.67 Bn | 1.51 Bn | 27.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.68% |
| Dec 31, 2025 | -60.28% |
| Sep 30, 2025 | 25.69% |
| Jun 30, 2025 | -14.60% |
| Mar 31, 2025 | 9.93% |
| Dec 31, 2024 | 9.82% |
| Sep 30, 2024 | 4.84% |
| Jun 30, 2024 | 6.58% |
| Mar 31, 2024 | -18.76% |
| Dec 31, 2023 | 1,351.59% |
| Sep 30, 2023 | 8.68% |
| Jun 30, 2023 | 17.34% |
| Mar 31, 2023 | 64.97% |
| Dec 31, 2022 | -121.15% |
| Sep 30, 2022 | 0.95% |
| Jun 30, 2022 | 24.96% |
| Mar 31, 2022 | 2,581.08% |
| Dec 31, 2021 | -67.49% |
| Sep 30, 2021 | -18.78% |
| Jun 30, 2021 | 230.93% |